Regenerx Biopharmaceuticals Inc (RGRX)
0.0014
0.00 (0.00%)
USD |
OTCM |
Nov 04, 16:00
Regenerx Biopharmaceuticals Total Assets (Quarterly): 0.1868M for March 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 0.1868M |
December 31, 2022 | 0.3822M |
September 30, 2022 | 0.581M |
June 30, 2022 | 0.7355M |
March 31, 2022 | 0.9605M |
December 31, 2021 | 1.285M |
September 30, 2021 | 1.594M |
June 30, 2021 | 2.111M |
March 31, 2021 | 0.3154M |
December 31, 2020 | 0.5518M |
September 30, 2020 | 0.2804M |
June 30, 2020 | 0.4926M |
March 31, 2020 | 0.6709M |
December 31, 2019 | 0.7118M |
September 30, 2019 | 0.9709M |
June 30, 2019 | 1.264M |
March 31, 2019 | 0.7504M |
December 31, 2018 | 0.281M |
September 30, 2018 | 0.4425M |
June 30, 2018 | 0.7124M |
March 31, 2018 | 0.9551M |
December 31, 2017 | 0.2271M |
September 30, 2017 | 0.2241M |
June 30, 2017 | 0.2905M |
March 31, 2017 | 0.5413M |
Date | Value |
---|---|
December 31, 2016 | 0.8624M |
September 30, 2016 | 1.202M |
June 30, 2016 | 1.649M |
March 31, 2016 | 0.1138M |
December 31, 2015 | 0.3582M |
September 30, 2015 | 0.7112M |
June 30, 2015 | 0.6363M |
March 31, 2015 | 1.132M |
December 31, 2014 | 0.9492M |
September 30, 2014 | 1.322M |
June 30, 2014 | 0.7626M |
March 31, 2014 | 1.358M |
December 31, 2013 | 0.0427M |
September 30, 2013 | 0.2024M |
June 30, 2013 | 0.0261M |
March 31, 2013 | 0.2626M |
December 31, 2012 | 0.3566M |
September 30, 2012 | 0.109M |
June 30, 2012 | 0.3083M |
March 31, 2012 | 0.286M |
December 31, 2011 | 0.3836M |
September 30, 2011 | 0.6527M |
June 30, 2011 | 3.033M |
March 31, 2011 | 4.167M |
December 31, 2010 | 4.228M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
0.1868M
Minimum
Mar 2023
2.111M
Maximum
Jun 2021
0.7756M
Average
0.6259M
Median
Total Assets (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | 5.736M |
FluoroPharma Medical Inc | 0.3348M |
Evolutionary Genomics Inc | 2.354M |
Xeno Transplants Corp | -- |
Entia Biosciences Inc | 0.4391M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 3.931M |
Shareholders Equity (Quarterly) | -3.744M |